Insmed (INSM) Capital Leases (2010 - 2026)

Insmed's Capital Leases history runs 12 years deep, the most recent figure standing at $19.8 million for Q1 2026.

• On a quarterly basis, Capital Leases fell 14.81% year-over-year to $19.8 million in Q1 2026; TTM through Mar 2026 was $19.8 million, a 14.81% decrease from a year earlier, with the FY2025 full-year figure at $20.7 million, down 13.9% from the prior year.
• Capital Leases slipped to $19.8 million in Q1 2026 per INSM's latest filing, from $20.7 million in the prior quarter.
• Across five years, Capital Leases topped out at $29.6 million in Q4 2022 and bottomed at $19.8 million in Q1 2026.
• The 5-year median for Capital Leases is $24.1 million (2024), against an average of $24.7 million.
• Across the five-year window, Capital Leases surged 110.14% in 2022 and fell 14.81% in 2026, its largest moves.
• Year by year, Capital Leases stood at $29.6 million in 2022, then dropped by 8.81% to $27.0 million in 2023, then retreated by 10.96% to $24.1 million in 2024, then dropped by 13.9% to $20.7 million in 2025, then fell by 4.34% to $19.8 million in 2026.
• Per Business Quant, the three latest INSM Capital Leases figures stand at $19.8 million (Q1 2026), $20.7 million (Q4 2025), and $21.6 million (Q3 2025).